Login / Signup

The role of EDIL3 in maintaining cartilage extracellular matrix and inhibiting osteoarthritis development.

Mei-Feng ChenChih-Chien HuYung-Heng HsuSheng-Hsun LeeKai-Lin ChenSteve W N UengYuhan Chang
Published in: Bone & joint research (2023)
EDIL3 has a role in maintaining the cartilage ECM and inhibiting the development of OA, making it a potential therapeutic drug for OA.
Keyphrases
  • extracellular matrix
  • knee osteoarthritis
  • signaling pathway
  • rheumatoid arthritis
  • emergency department
  • drug induced